Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
31 hedge funds and large institutions have $5.18M invested in Nemaura Medical, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 3 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 30 → 31 (+1)
4% less capital invested
Capital invested by funds: $5.39M → $5.18M (-$206K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$85.9K |
| 2 |
Invesco
Atlanta,
Georgia
|
+$57.7K |
| 3 |
JP Morgan Chase
New York
|
+$55.1K |
| 4 |
VF
Virtu Financial
New York
|
+$43K |
| 5 |
Morgan Stanley
New York
|
+$18.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$461K |
| 2 |
AC
Armistice Capital
New York
|
-$315K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$36K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$14.9K |
| 5 |
State Street
Boston,
Massachusetts
|
-$9.64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Legal & General Group
London,
United Kingdom
| $4K | – | – | – |
|
|
AIP
27
Ameritas Investment Partners
Lincoln,
Nebraska
| $2K | – | – | – |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$1.75K | +453 | +2,384% |
|
|
AIG
29
American International Group
New York
| $16 | -$474 | -123 | -3% |
|
|
AC
30
Armistice Capital
New York
| – | -$315K | -88,830 | Closed |
|
31
Osaic Holdings
Scottsdale,
Arizona
| – | -$5K | -1,500 | Closed |
|
|
ASN
32
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -250 | Closed |
|
33
Fidelity Investments
Boston,
Massachusetts
| – | +$170 | +44 | New |
|
NMRD Hedge Fund Activity: Q4 2020 in Review
31 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q4 2020, worth a combined $5.18M — down 3.8% from $5.39M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NMRD positions and 3 closed out — a net gain of 1 holder — while 12 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock, adding an estimated $85.9K. The largest seller was Sabby Management, cutting an estimated $461K.
- 31 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q4 2020, up from 30 in Q3 2020.
- Funds reported $5.18M of Nemaura Medical, Inc. Common Stock stock for Q4 2020, down 3.8% quarter-over-quarter.
- 4 funds opened new Nemaura Medical, Inc. Common Stock positions in Q4 2020 and 3 closed out, a net change of +1 holder.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q4 2020 was BlackRock, an estimated $85.9K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q4 2020 was Sabby Management, an estimated $461K sold.
Based on aggregated 13F filings for Q4 2020.